818
Views
1
CrossRef citations to date
0
Altmetric
Review

Ocular ischaemia: signs, symptoms, and clinical considerations for primary eye care practitioners

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon & show all
Pages 117-134 | Received 23 Jul 2021, Accepted 25 Oct 2021, Published online: 04 Jan 2022

References

  • AIHW (Australian Institute of Health Welfare. Stroke. Canberra: AIHW; 2020.
  • Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38:208–211.
  • Kamal N, Sheng S, Xian Y, et al. Delays in door-to-needle times and their impact on treatment time and outcomes in get with the guidelines-stroke. Stroke. 2017;48:946–954.
  • Robbins NM, and Swanson RA. Opposing effects of glucose on stroke and reperfusion injury. Stroke. 2014;45:1881–1886.
  • Purdy EP. Section 1: update on general medicine 2013-2014 1st Edition. In: Basic and clinical science course. 1st ed. San Francisco, CA: American Academy of Ophthalmology; 2013.
  • Andersen KK, Olsen TS, Dehlendorff C, et al. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40:2068–2072.
  • A classification and outline of cerebrovascular diseases. II. Stroke. 1975;6:564–616.
  • Nadarajan V, Perry RJ, Johnson J, et al. Transient ischaemic attacks: mimics and chameleons. Pract Neurol. 2014;14:23–31.
  • Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276–2293.
  • Albers GW, Caplan LR, Easton JD, et al. Transient ISCHEMIC ATTACK — PROPOSAL FOR A NEW DEFINITION. N Engl J Med. 2002;347:1713–1716.
  • Sacco RL, Kasner SE, Broderick JP, et al. An Updated definition of stroke for the 21st century. Stroke. 2013;44:2064–2089.
  • Biousse V, Nahab F, Newman NJ. Management of acute retinal ischemia: follow the guidelines! Ophthalmology. 2018;125:1597–1607.
  • Moss HE. Retinal vascular changes are a marker for cerebral vascular diseases. Curr Neurol Neurosci Rep. 2015;15:40.
  • Nouh A, Remke J, Ruland S. Ischemic posterior circulation stroke: a review of anatomy, clinical presentations, diagnosis, and current management. Front Neurol. 2014;5:30.
  • Australian Bureau of Statistics (ABS). National, state and territory population (September 2020). Canberra, Australian Capital Territory, Australia: Australian Government; 2021.
  • Biousse V, Newman NJ. Eye syndromes and the neuro-ophthalmology of stroke. Handb Clin Neurol. 2009;93:595–611.
  • Babikian V, Wijman CA, Koleini B, et al. Retinal ischemia and embolism. Etiologies and outcomes based on a prospective study. Cerebrovasc Dis. 2001;12:108–113.
  • Biousse V, Trobe JD. Transient Monocular Visual Loss. Am J Ophthalmol. 2005;140:717.e711–717.e718.
  • Dattilo M, Newman NJ, Biousse V. A cute retinal arterial ischemia. Ann Eye Sci. 2018;3:28.
  • Kiely PM, Slater J. Optometry Australia Entry-level Competency Standards for Optometry 2014. Clin Exp Optometry. 2015;98:65–89.
  • Panuganti KT, Lui P. Transient ischemic attack. Treasure Island (FL): StatPearls Publishing; 2020.
  • Wang H, Kalloniatis M. Clinical outcomes of the Centre for Eye Health: an intra-professional optometry-led collaborative eye care clinic in Australia. Clin Exp Optom. 2021;104:795-804.
  • Phu J, Hennessy MP, Spargo M, et al. A collaborative care pathway for patients with suspected angle closure glaucoma spectrum disease. Clin Exp Optom. 2020;103:212–219.
  • Jamous KF, Kalloniatis M, Hennessy MP, et al. Clinical model assisting with the collaborative care of glaucoma patients and suspects. Clin Exp Ophthalmol. 2015;43:308–319.
  • Schneider M, Molnar A, Angeli O, et al. Prevalence of Cilioretinal Arteries: a systematic review and a prospective cross-sectional observational study. Acta Ophthalmol. 2021;99:e310–e318.
  • Foroozan R. Section 5: neuro-Ophthalmology 2013-2014 1st Edition. In: Basic and Clinical Science Course. 1st ed. San Francisco, CA: American Academy of Ophthalmology; 2013.
  • Potter BJ, Pinto DS. Subclavian steal syndrome. Circulation. 2014;129:2320–2323.
  • Psillas G, Kekes G, Constantinidis J, et al. Subclavian steal syndrome: neurological manifestations.Acta otorhinolaryngologica Italica. 2007;27:33–37.
  • Filis K, Toufektzian L, Sigala F, et al. Right subclavian double steal syndrome: a case report. J Med Case Rep. 2008;2:392.
  • Hartkamp MJ, van Der Grond J, van Everdingen KJ, et al. Circle of Willis collateral flow investigated by magnetic resonance angiography. Stroke. 1999;30:2671–2678.
  • Morin R, Egan EA, Ferguson W, et al. Development of pulmonary vascular response to oxygen. Am J Physiol Heart Circ Physiol. 1988;254:H542–H546.
  • Eklof B, Schwartz SI. Effects of subclavian steal and compromised cephalic blood flow on cerebral circulation. Surg Forum. 1969;20:154–156.
  • Pula JH, Yuen CA. Eyes and stroke: the visual aspects of cerebrovascular disease. Stroke Vasc Neurol. 2017;2:210–220.
  • Otis S, Rush M, Thomas M, et al. Carotid steal syndrome following carotid subclavian bypass. J Vasc Surg. 1984;1:649–652.
  • Cho HJ, Song SK, Lee DW, et al. Carotid-subclavian steal phenomenon. Neurology. 2007;68:702.
  • Moran KT, Zide RS, Persson AV, et al. Natural history of subclavian steal syndrome. Am Surg. 1988;54:643–644.
  • Rawal AR, Bufano C, Saeed O, et al. Double steal phenomenon: emergency department management of recurrent transient ischemic attack. Clin Pract Cases Emerg Med. 2019;3:144–148.
  • Cugati S, Wang JJ, Rochtchina E, et al. Ten-year incidence of retinal emboli in an older population. Stroke. 2006;37:908–910.
  • Wang JJ, Cugati S, Knudtson MD, et al. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke. 2006;37:1833–1836.
  • Lauda F, Neugebauer H, Reiber L, et al. Acute silent brain infarction in monocular visual loss of ischemic origin. Cerebrovasc Dis. 2015;40:151–156.
  • Cho KH, Ahn SJ, Cho JH, et al. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2016;57:4589–4598.
  • Schubert HD. Section 12: retina and Vitreous 2013-2014 1st Edition. In: Basic and Clinical Science Course. 1st ed. San Francisco, CA: American Academy of Ophthalmology; 2013.
  • Hollenhorst RW, Lensink ER, Whisnant JP. Experimental embolization of the retinal arterioles. Trans Am Ophthalmol Soc. 1962;60:316–334.
  • Marc RE, Jones BW. Retinal remodeling in inherited photoreceptor degenerations. Mol Neurobiol. 2003;28:139–147.
  • Kalloniatis M, Nivison-Smith L, and Chua J, et al. Using the rd1 mouse to understand functional and anatomical retinal remodeling and treatment implications in retinitis pigmentosa: a review. Exp Eye Res. 2015; 150:106–121.
  • Strettoi E. A Survey of Retinal Remodeling. Front Cell Neurosci. 2015;9:494.
  • Tobalem S, Schutz JS, Chronopoulos A. Central retinal artery occlusion – rethinking retinal survival time. BMC Ophthalmol. 2018;18:101.
  • Takahashi H, Iijima H. Sectoral thinning of the retina after branch retinal artery occlusion. Jpn J Ophthalmol. 2009;53:494–500.
  • Sun D, Vingrys AJ, Kalloniatis M. Metabolic and functional profiling of the ischemic/reperfused rat retina. J Comp Neurol. 2007;505:114–130.
  • Sun D, Bui BV, Vingrys AJ, et al. Alterations in photoreceptor-bipolar cell signaling following ischemia/reperfusion in the rat retina. J Comp Neurol. 2007;505:131–146.
  • Wajngarten M, Silva GS. Hypertension and stroke: update on treatment. Eur Cardiol. 2019;14:111–115.
  • Wong T, Mitchell P. The eye in hypertension. Lancet. 2007;369:425–435.
  • Xu L, Zhou JQ, Wang S, et al. Localized retinal nerve fiber layer defects and arterial hypertension. Am J Hypertens. 2013;26:511–517.
  • Wang D, Li Y, Wang C, et al. Localized retinal nerve fiber layer defects and stroke. Stroke. 2014;45:1651–1656.
  • Wang S, Xu L, Jonas JB, et al. Five-year incidence of retinal microvascular abnormalities and associations with arterial hypertension: the Beijing Eye Study 2001/2006. Ophthalmology. 2012;119:2592–2599.
  • Xiao H, Liu X, Lian P, et al. Different damage patterns of retinal nerve fiber layer and ganglion cell-inner plexiform layer between early glaucoma and non-glaucomatous optic neuropathy. Int J Ophthalmol. 2020;13:893–901.
  • Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780.
  • Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-141; discussion 141-133.
  • Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology. 1993;100:423–428.
  • Henkind P, Wise GN. Retinal neovascularization, collaterals, and vascular shunts. Br J Ophthalmol. 1974;58:413–422.
  • de Smet MD, Gad Elkareem AM, Zwinderman AH. The vitreous, the retinal interface in ocular health and disease. Ophthalmologica. 2013;230:165–178.
  • Mansour AM, Kozak I, Saatci AO, et al. Prepapillary vascular loop-a new classification. Eye. 2021;35:425–432.
  • Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. 2012;18:Ra138–144.
  • Avery MB, Magal I, Kherani A, et al. Risk of Stroke In Patients With Ocular Arterial Occlusive Disorders: A Retrospective Canadian Study. J Am Heart Assoc. 2019;8:e010509.
  • Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol. 1991;15:15–20.
  • Rowe FJ. Stroke survivors’ views and experiences on impact of visual impairment. Brain Behav. 2017;7:e00778.
  • Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55:2–34.
  • Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239–251.
  • Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–864.
  • Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist. 2008;14:341–354.
  • Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol. 2011;59:123–136.
  • Ciofalo A, Gulotta G, Iannella G, et al. Giant Cell Arteritis (GCA): pathogenesis, Clinical Aspects and Treatment Approaches. Curr Rheumatol Rev. 2019;15:259–268.
  • De Smit E, O’Sullivan E, Mackey DA, et al. Giant cell arteritis: ophthalmic manifestations of a systemic disease. Graefes Arch Clin Exp Ophthalmol. 2016;254:2291–2306.
  • Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11:A544–A554.
  • Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Bmj. 1989;299:549–550.
  • Uddhammar A, Eriksson A-L, Nyström L, et al. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29:737–742.
  • Agarwal PC, Gupta S, Thakur A, et al. Optic disc oedema: a diagnostic dilemma. BMJ Case Rep. 2011;2011.
  • Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125:509–520.
  • Samson M, Jacquin A, Audia S, et al. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry. 2015;86:216–221.
  • Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004;17:27–35.
  • Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol. 1997;124:641–647.
  • Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:1107–1121.
  • Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108:593–598.
  • Kalogeris T, Bao Y, Korthuis RJ. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2014;2:702–714.
  • Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91–147.
  • Kostandy BB. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci. 2012;33:223–237.
  • Robin LN, Kalloniatis M. Interrelationship between retinal ischaemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA. Doc Ophthalmol. 1992;80:273–300.
  • Bui BV, Vingrys AJ, Kalloniatis M. Correlating retinal function and amino acid immunocytochemistry following post-mortem ischemia. Exp Eye Res. 2003;77:125–136.
  • Napper GA, Kalloniatis M. Neurochemical changes following postmortem ischemia in the rat retina. Vis Neurosci. 1999;16:1169–1180.
  • Napper GA, Pianta MJ, Kalloniatis M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Vis Neurosci. 1999;16:149–158.
  • Napper GA, Pianta MJ, Kalloniatis M. Localization of amino acid neurotransmitters following in vitro ischemia and anoxia in the rat retina. Vis Neurosci. 2001;18:413–427.
  • Blair NP, Tan MR, Felder AE, et al. Retinal oxygen delivery, metabolism and extraction fraction and retinal thickness immediately following an interval of ophthalmic vessel occlusion in rats. Sci Rep. 2019;9:8092.
  • Szabo ME, Droy-Lefaix MT, Doly M, et al. Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. Invest Ophthalmol Vis Sci. 1991;32:1471–1478.
  • Coady PA, Cunningham ET Jr., Vora RA, et al. Spectral domain optical coherence tomography findings in eyes with acute ischaemic retinal whitening. Br J Ophthalmol. 2015;99:586–592.
  • Ritter M, Sacu S, Deák GG, et al. In vivo identification of alteration of inner neurosensory layers in branch retinal artery occlusion. Br J Ophthalmol. 2012;96:201–207.
  • Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium. 2010;47:122–129.
  • Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 2015;6:524–551.
  • Ho JK, Stanford MP, Shariati MA, et al. Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation. Invest Ophthalmol Vis Sci. 2013;54:5981–5988.
  • Shariati MA, Park JH, Liao YJ. Optical coherence tomography study of retinal changes in normal aging and after ischemia. Invest Ophthalmol Vis Sci. 2015;56:2790–2797.
  • Fu CT, Sretavan DW. Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma. J Neurosci. 2012;32:15859–15876.
  • Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, et al. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 2002;109:157–168.
  • Yamamoto H, Schmidt-Kastner R, Hamasaki DI, et al. Complex neurodegeneration in retina following moderate ischemia induced by bilateral common carotid artery occlusion in Wistar rats. Exp Eye Res. 2006;82:767–779.
  • Renner M, Stute G, Alzureiqi M, et al. Optic nerve degeneration after retinal ischemia/reperfusion in a rodent model. Front Cell Neurosci. 2017;11:254.
  • Palmhof M, Wagner N, Nagel C, et al. Retinal ischemia triggers early microglia activation in the optic nerve followed by neurofilament degeneration. Exp Eye Res. 2020;198:108133.
  • So K-F., Cui Qi, Li H-Y., et al. Mechanisms of secondary degeneration after partial optic nerve transection. Neural Regen Res. 2014;9:565–574.
  • Nivison-Smith L, Acosta ML, Misra S, et al. Vinpocetine regulates cation channel permeability of inner retinal neurons in the ischaemic retina. Neurochem Int. 2014;66:1–14.
  • Nivison-Smith L, Khoo P, Acosta ML, et al. Vinpocetine protects inner retinal neurons with functional NMDA glutamate receptors against retinal ischemia. Exp Eye Res. 2018;167:1–13.
  • Nivison-Smith L, O’Brien BJ, Truong M, et al. Vinpocetine modulates metabolic activity and function during retinal ischemia. Am J Physiol Cell Physiol. 2015;308:C737–749.
  • Sun D, Lye-Barthel M, Masland RH, et al. Structural remodeling of fibrous astrocytes after axonal injury. J Neurosci. 2010;30:14008–14019.
  • Sun D, Qu J, Jakobs TC. Reversible reactivity by optic nerve astrocytes. Glia. 2013;61:1218–1235.
  • Nishijima K, Ng Y-S, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171:53–67.
  • Zadeh JK, Garcia-Bardon A, Hartmann EK, et al. Short-Time ocular ischemia induces vascular endothelial dysfunction and ganglion cell loss in the pig retina. Int J Mol Sci. 2019;20:4685.
  • Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905–909.
  • Norton K-A, Popel AS. Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep. 2016;6:36992.
  • Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 2007;80:51–60.
  • Havens SJ, Gulati V. Neovascular Glaucoma. Dev Ophthalmol. 2016;55:196–204.
  • Magargal LE, Donoso LA, Sanborn GE. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology. 1982;89:1241–1245.
  • Palmhof M, Frank V, Rappard P, et al. From ganglion cell to photoreceptor layer: timeline of deterioration in a rat ischemia/reperfusion model. Front Cell Neurosci. 2019;13:174.
  • Zheng L, Gong B, Hatala DA, et al. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci. 2007;48:361–367.
  • D’Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974–3979.
  • Aiello LP, Pierce EA, Foley ED, et al. Suppression of Retinal Neovascularization in vivo by Inhibition of Vascular Endothelial Growth Factor (VEGF) Using Soluble VEGF-Receptor Chimeric Proteins. Proc Natl Acad Sci U S A. 1995;92:10457–10461.
  • Ozaki H, Yu AY, Della N, et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999;40:182–189.
  • Gao G, Li Y, Zhang D, et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001;489:270–276.
  • Magyar MT, Nam EM, Csiba L, et al. Carotid artery auscultation–anachronism or useful screening procedure? Neurol Res. 2002;24:705–708.
  • Yang S, Liu X, Li H, et al. Optical coherence tomography angiography characteristics of acute retinal arterial occlusion. BMC Ophthalmol. 2019;19:147.
  • Sugiyama T, Araie M, Riva CE, et al. Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol. 2010;88:723–729.
  • Motoyama Y, Hayashi H, Kawanishi H, et al. Ocular blood flow by laser speckle flowgraphy to detect cerebral ischemia during carotid endarterectomy. J Clin Monit Comput. 2021;35:327–336.
  • Kunikata H, and Nakazawa T. Recent clinical applications of laser speckle flowgraphy in eyes with retinal disease. Asia-Pac J Ophthalmol. 2016;5:151–158.
  • Vodopivec I, Rizzo JF III. Ophthalmic manifestations of giant cell arteritis. Rheumatology. 2018;57:ii63–ii72.
  • Coutts SB. Diagnosis and Management of Transient Ischemic Attack. Continuum (Minneap Minn). 2017;23:82–92.
  • Sanders RD. The Trigeminal (V) and Facial (VII) Cranial Nerves: head and Face Sensation and Movement. Psychiatry (Edgmont). 2010;7:13–16.
  • Selwaness M, Bos D, van den Bouwhuijsen Q, et al. Carotid atherosclerotic plaque characteristics on magnetic resonance imaging relate with history of stroke and coronary heart disease. Stroke. 2016;47:1542–1547.
  • Nadareishvili ZG, Rothwell PM, Beletsky V, et al. Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. Arch Neurol. 2002;59:1162–1166.
  • Howard DPJ, Gaziano L, Rothwell PM. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2021;20:193–202.
  • Den Hartog AG, Achterberg S, Moll FL, et al. Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinical manifest arterial disease. Stroke. 2013;44:1002–1007.
  • Albucher JF, Martel P, Mas JL. Clinical practice guidelines: diagnosis and immediate management of transient ischemic attacks in adults. Cerebrovasc Dis. 2005;20:220–225.
  • Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–292.
  • Hayreh SS. Do patients with retinal artery occlusion need urgent neurologic evaluation? Am J Ophthalmol. 2018;196:53–56.
  • Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 1980;87:75–78.
  • Cugati S, Varma DD, Chen CS, et al. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol. 2013;15:63–77.
  • Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637–676.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.